Cardiff Lexington Subsidiary Nova Ortho and Spine Announces New Healthcare Hires to Support Growth
Rhea-AI Summary
Cardiff Lexington (OTCQB: CDIX) subsidiary Nova Ortho and Spine expanded its Florida clinical team on February 26, 2026 by hiring two procedurally trained nurse practitioners to support rising patient volume across Orlando and southeastern Florida.
The hires—Catherine Amanda Kelly, MSN, APRN, FNP-BC, and Ashley Logan, APRN-BC—bring combined procedural, neurosurgery, orthopedic surgery and pain management experience intended to improve operational efficiency, safety and patient satisfaction.
Positive
- None.
Negative
- None.
Key Figures
Market Reality Check
Peers on Argus
CDIX fell 10.53% while close peers were mixed: NUMIF up 3.44%, VLXC down 23.08%, others flat to slightly negative, pointing to stock-specific pressure rather than a broad sector move.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Jan 20 | Uplisting S-1 filing | Positive | +29.5% | Announced Form S-1 filing and Nasdaq uplisting strategy with investment bank. |
| Jan 12 | Reverse stock split | Negative | +29.5% | Implemented 1-for-3 reverse split to support Nasdaq bid price compliance. |
| Dec 29 | Leadership transition | Neutral | +1.7% | Longtime chairman retired; CEO Alex Cunningham assumed chairman role. |
| Dec 11 | Clinical expansion | Positive | -1.2% | Nova Ortho and Spine performed first procedures at rural Florida hospital. |
| Nov 20 | Advisory agreement | Positive | -57.7% | Engaged Greentree Financial to support uplisting and governance initiatives. |
Recent expansion/uplisting news often met with volatile and sometimes contrary price moves, including sharp declines on seemingly positive corporate developments.
Over the past few months, Cardiff Lexington has focused on uplisting and expanding Nova Ortho and Spine. The company entered an advisory agreement with Greentree Financial on Nov 20, 2025 and later announced an S-1 filing on Dec 15, 2025, with that uplisting news driving a 29.49% move the following month. Operationally, Nova Ortho and Spine began procedures at a Florida hospital on Dec 11, 2025. Governance shifted as Daniel Thompson retired on Dec 31, 2025, with Alex Cunningham becoming Chairman. Today’s hiring news continues the theme of building Nova Ortho and Spine’s Florida footprint.
Market Pulse Summary
This announcement adds two experienced nurse practitioners to Nova Ortho and Spine’s Florida operations, supporting rising patient volumes and geographic reach. It follows recent milestones such as first procedures at a new Florida hospital on Dec 11, 2025 and ongoing uplisting preparation via an S-1 filed on Dec 15, 2025. Investors may watch for sustained revenue growth, clinic utilization, and updates on capital formation and governance improvements highlighted in recent SEC disclosures.
Key Terms
aprn medical
fnp-bc medical
neurosurgery medical
AI-generated analysis. Not financial advice.
LEXINGTON, KY / ACCESS Newswire / February 26, 2026 / Cardiff Lexington Corporation (OTCQB:CDIX), a healthcare holding company with deep leadership and operational expertise in Orthopedics, Spine Care, and Pain Management, today announced that the Company's subsidiary, Nova Ortho and Spine, LLC, has expanded its Florida team with the hiring of two highly qualified procedurally trained and certified nurse practitioners to support increased patient volume and demand throughout the region. These hires demonstrate Cardiff Lexington's ongoing commitment to providing best-in-class healthcare to patient populations throughout Florida, and the continued execution of the Company's growth strategy for Nova Ortho and Spine.
Catherine Amanda Kelly, MSN, APRN, FNP-BC, brings 20 years of clinical experience across procedural, emergency and hospital medicine that should contribute to the growth of Nova Ortho and Spine in Orlando and the Southeastern regions of Florida.
Ashley Logan, APRN- BC, has an extensive background in neurosurgery, orthopedic surgery and pain management. Her experience with procedure medicine, imaging and symptomology evaluations makes her a valuable addition to Nova Ortho and Spine, and her operational expertise will help to significantly improve efficiency, safety and overall patient satisfaction.
Alex Cunningham, Chief Executive Officer of Cardiff Lexington, commented, "We're very pleased to enhance our team at Nova Ortho and Spine with two highly qualified nurse practitioners with deep experience in the surgical and pain management fields. These new hires support the ongoing growth of Nova Ortho and Spine and the increasing patient volumes that we continue to see throughout Florida. We remain committed to expanding our healthcare footprint with the goal of providing best-in-class healthcare to patient populations throughout the state."
Dr. Kevin Fitzgerald, Chief Medical Officer of Nova Ortho and Spine, commented, "We're excited to officially welcome Catherine and Ashley to the Nova Ortho and Spine team. Their medical and operational expertise have played an integral role in supporting the increasing patient volume that we're seeing across our network of locations as demand for our services continues to grow."
About Cardiff Lexington Corporation
Cardiff Lexington Corporation (OTCQB:CDIX) is a targeted healthcare holding company dedicated to acquiring and building middle-market niche health care clinics, primarily in Orthopedics, Spine Care, and Pain Management. The Company's partnership-driven culture emphasizes service excellence, teamwork, accountability, and performance.
All current revenue is derived from Nova Ortho and Spine, LLC, which operates a network of regional specialty and ancillary orthopedic care centers across Florida and Georgia. These facilities provide traumatic injury patients with comprehensive diagnostic and surgical services, primary care evaluations, interventional pain management, and specialty consultations.
For more information on Cardiff Lexington Corporation, you may access the company's website at https://cardifflexington.com/
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are based on current expectations, estimates, and projections and involve risks and uncertainties that could cause actual results to differ materially. Cardiff Lexington Corporation undertakes no obligation to update or revise forward-looking statements except as required by law.
Investor Contact
Cardiff Lexington Investor Relations
investorsrelations@cardifflexington.com
(800) 628-2100 ext. 705
or
IMS Investor Relations
cardifflexington@imsinvestorrelations.com
(203) 972-9200
SOURCE: Cardiff Lexington Corporation
View the original press release on ACCESS Newswire